ENFN
Enfusion, Inc. (ENFN) 10Y Growth Potential Analysis (2026)
Overall Score
Growth Runway
Revenue base remains small, leaving room for multi-year expansion if execution continues.
Gross margin is strong at 67.8%, supporting scalable growth economics.
Profitability
Operating margin is only 3.1% and net margin is 1.4%, indicating profitability is still thin.
Return on invested capital is 1.9%, showing limited current capital efficiency despite positive cash generation.
Financial Strength
Liquidity is solid with a current ratio of 3.4 and cash ratio of 2.0.
Balance sheet leverage is modest, with debt-to-equity at 0.28 and net debt to EBITDA negative at -5.6.
Cash Generation
Free cash flow yield is 3.0%, which is positive but not yet compelling for a premium growth multiple.
Capital intensity is low, with capex only 10.5% of operating cash flow.
Valuation
Valuation remains rich at 4.9x EV/sales and 32.9x price to free cash flow.
Earnings-based multiples are extremely elevated because trailing earnings are still minimal.
Sources
- Company filings (10-K, 10-Q, investor presentations)
- Financial and market data providers
- Public news and industry information
🔒 Go Beyond This Framework
This is one of 10 institutional-grade frameworks Invetso runs on Enfusion, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

